Cancer Drug Recalled by Bristol-Meyers
Bristol-Myers Squibb Co. is recalling more than 31,000 units of a chemotherapy drug after discovering a vial that was overfilled. Injecting too much of this drug could put patients at risk of an overdose.
The recall affects 10 lots of BiCNU, an injection of the drug carmustine. Carmustine is frequently used to treat brain tumors, multiple myeloma, Hodgkin’s disease and non-Hodgkin’s lymphoma. Bristol-Myers says taking too much of the drug can cause lung or kidney toxicity. According to the Associated Press, no adverse events have been reported at this time.
The recalled product was sold in the United States, Canada, Europe, Latin America, and Asia.
Patients and medical professionals can receive additional information regarding the recall by contacting Bristol-Myers Squibb at 1-888-896-4564.